What Is an Antibody Test? Characteristics of Antibodies against SARS-CoV-2 and Their Tests

被引:0
|
作者
Ishii-Watabe, Akiko [1 ]
机构
[1] Natl Inst Hlth Sci, Div Biol Chem & Biol, Kawasaki Ku, 3-25-26 Tonomachi, Kawasaki, Kanagawa 2109501, Japan
关键词
severe acute respiratory syndrome coronavirus-2; vaccine; antibody test; immunoglobulin G (IgG); immunoglobulin M (IgM);
D O I
10.1248/yakushi.21-00234-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antibodies play a major role in immune responses against viruses, which inhibit infection by binding to target viral antigen. Antibodies are induced by viral entry to the body and vaccination that artificially induces immune responses; therefore, antibody tests are used in research for infection history and evaluation of vaccine efficacy. Currently, antibody tests against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) by immunochromatography, enzyme-linked immunosorbent assay (ELISA), and electrochemiluminescence immunoassay (ECLIA), or other kits used for automated analyzer are available. However, the test results should be carefully interpreted because requirements for the antibody test to obtain reliable results have not been established. Also, antibodies in human samples are heterogeneous, and their expression level changes over time. This review briefly explains the basic knowledge about antibodies against SARS-CoV-2 and outlines the classification and characteristics of the antibody tests with points to consider in their use. A summary of the collaborative study that evaluated the analytical performance of antibody test kits conducted by the National Institute of Health Sciences is also introduced. Then, the issues in ensuring the reliability of antibody tests results are discussed by considering the usefulness and availability of the World Health Organization international standard for anti-SARS-CoV-2 immunoglobulin.
引用
下载
收藏
页码:611 / 618
页数:8
相关论文
共 50 条
  • [41] The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
    Xia, Yong
    Hong, Honghai
    Feng, Yao
    Liu, Meiling
    Pan, Xingfei
    Chen, Dexiong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 : 359 - 360
  • [42] Antibodies against SARS-CoV-2 after natural infection in healthcare workers and clinical characteristics as putative antibody production prediction
    Hanssen, D. A. T.
    Penders, J.
    Heijgele, K.
    de Leede, S.
    Mulder, M.
    Bank, L. E. A.
    Slaats, M. H. C.
    Savelkoul, P. H. M.
    van Loo, I. H. M.
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2022, 2 (03):
  • [43] Clinical performance evaluation of a SARS-CoV-2 Rapid Antibody Test for determining past exposure to SARS-CoV-2
    Findeisen, Peter
    Stiegler, Hugo
    Lopez-Calle, Eloisa
    Schneider, Tanja
    Urlaub, Eva
    Hayer, Johannes
    Zemmrich, Claudia
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 103 : 636 - 641
  • [44] Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
    Xie, Jiajia
    Ding, Chengchao
    He, Jun
    Zhang, Yuqing
    Ni, Shuangshuang
    Zhang, Xiangyu
    Chen, Qingqing
    Wang, Jing
    Huang, Lina
    He, Hongliang
    Li, Wenting
    Ma, Huan
    Jin, Tengchuan
    Zhang, Siping
    Gao, Yong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [45] Clinical performance of different SARS-CoV-2 IgG antibody tests
    Kohmer, Niko
    Westhaus, Sandra
    Ruehl, Cornelia
    Ciesek, Sandra
    Rabenau, Holger F.
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 2243 - 2247
  • [46] Antibody tests for identification of current and past infection with SARS-CoV-2
    Deeks, Jonathan J.
    Dinnes, Jacqueline
    Takwoingil, Yemisi
    Davenport, Clare
    Spijker, Ren
    Taylor-Phillips, Sian
    Adrianol, Ada
    Beesel, Sophie
    Dretzkel, Janine
    di Ruffanol, Lavinia Ferrante
    Harris, Isobel M.
    Price, Malcolm J.
    Dittrich, Sabine
    Emperador, Devy
    Hooft, Lotty
    Leeflang, Mariska M. G.
    Van den Bruel, Ann
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (06):
  • [47] Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera
    Kannenberg, Judith
    Schnurra, Carolin
    Reiners, Nina
    Henschler, Reinhard
    Buhmann, Raymund
    Kaiser, Thorsten
    Biemann, Ronald
    Hoenemann, Mario
    Ackermann, Grit
    Trawinski, Henning
    Jassoy, Christian
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2021, 1 (03):
  • [48] Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
    Drosos, Alexandros A.
    Pelechas, Eleftherios
    Drossou, Vassiliki
    Voulgari, Paraskevi V.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 379 - 389
  • [49] Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
    Alexandros A. Drosos
    Eleftherios Pelechas
    Vassiliki Drossou
    Paraskevi V. Voulgari
    Rheumatology and Therapy, 2022, 9 : 379 - 389
  • [50] Serological Tests in Blood Donors in the greater Magdeburg Area for antibodies against SARS-CoV-2 (SeMaCo)
    Pohl, R.
    Heuft, H-G
    Kaasch, A.
    Kraemer, S. W.
    Stallmann, C.
    Swart, E.
    Apfelbacher, C.
    GESUNDHEITSWESEN, 2021, 83 (08/09) : 715 - 715